|
Status |
Public on Jul 01, 2022 |
Title |
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
35731891, 37621719 |
|
Submission date |
Jan 05, 2022 |
Last update date |
Sep 14, 2023 |
Contact name |
Yujin Hoshida |
Organization name |
University of Texas Southwestern Medical Center
|
Street address |
5323 Harry Hines Blvd
|
City |
Dallas |
State/province |
TX |
ZIP/Postal code |
75390 |
Country |
USA |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (271)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE192959 |
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (derivation set). |
GSE193066 |
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (tissue validation set 1). |
GSE193080 |
Transcriptome profile of liver biopsy tissues from patients with non-alcoholic fatty liver disease (tissue validation set 2). |
GSE200460 |
Prognostic Liver Signature for NAFLD (PLS-NAFLD) profiles of cell-based PLS system treated with free fatty acids (FFA) and IDO1 inhibitor, epacadostat. |
|
Relations |
BioProject |
PRJNA794736 |